Status:
RECRUITING
Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes
Lead Sponsor:
University of Colorado, Denver
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
2-26 years
Brief Summary
This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.
Detailed Description
This study is an observational study design that includes collection of continuous glucose data and venous blood glucose data (from either an IV or fingerstick) from a blood glucose meter. All subject...
Eligibility Criteria
Inclusion
- Participants will be 2 to 26 years of age at the time of enrollment.
- Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.
- Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.
Exclusion
- Pregnancy.
- Currently using hydroxyurea.
- A condition that the investigator determines would prevent the patient from participation.
Key Trial Info
Start Date :
August 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06575842
Start Date
August 21 2024
End Date
September 1 2025
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barbara Davis Center
Aurora, Colorado, United States, 80045